97 related articles for article (PubMed ID: 8320067)
1. Enhancement of the echogenicity of flowing blood by the contrast agent perflubron.
André MP; Steinbach G; Mattrey RF
Invest Radiol; 1993 Jun; 28(6):502-6. PubMed ID: 8320067
[TBL] [Abstract][Full Text] [Related]
2. Physical and acoustical properties of perfluorooctylbromide, an ultrasound contrast agent.
André M; Nelson T; Mattrey R
Invest Radiol; 1990 Sep; 25(9):983-7. PubMed ID: 2211056
[TBL] [Abstract][Full Text] [Related]
3. Perfluorooctylbromide as a contrast agent for CT and sonography: preliminary clinical results.
Behan M; O'Connell D; Mattrey RF; Carney DN
AJR Am J Roentgenol; 1993 Feb; 160(2):399-405. PubMed ID: 8424361
[TBL] [Abstract][Full Text] [Related]
4. Time versus density enhancement of liver, spleen, and great vessels following rapid intravenous infusion of perflubron emulsion.
Harned RK; Fruman SA; Swenson RB; Bernardino ME
Acad Radiol; 1995 Jan; 2(1):38-42. PubMed ID: 9419522
[TBL] [Abstract][Full Text] [Related]
5. Ultrasonic attenuation and backscatter from flowing whole blood are dependent on shear rate and hematocrit between 10 and 50 MHz.
Huang CC; Chang YC
IEEE Trans Ultrason Ferroelectr Freq Control; 2011 Feb; 58(2):357-68. PubMed ID: 21342821
[TBL] [Abstract][Full Text] [Related]
6. Aggregation effects in whole blood: influence of time and shear rate measured using ultrasound.
Shehada RE; Cobbold RS; Mo LY
Biorheology; 1994; 31(1):115-35. PubMed ID: 8173041
[TBL] [Abstract][Full Text] [Related]
7. 19F chemical shift imaging technique to measure intracellular pO2 in vivo using perflubron.
Tran HT; Guo Q; Schumacher DJ; Buxton RB; Mattrey RF
Acad Radiol; 1995 Sep; 2(9):756-61. PubMed ID: 9419636
[TBL] [Abstract][Full Text] [Related]
8. Compatibility of different colloid plasma expanders with perflubron emulsion: an intravital microscopic study in the hamster.
Nolte D; Pickelmann S; Lang M; Keipert P; Messmer K
Anesthesiology; 2000 Nov; 93(5):1261-70. PubMed ID: 11046215
[TBL] [Abstract][Full Text] [Related]
9. Echo contrast agents improve flow display of color Doppler: in vitro studies.
Von Bibra H; Stempfle H; Poll A; Schlief R; Emslander H
Echocardiography; 1991 Sep; 8(5):533-40. PubMed ID: 10149269
[TBL] [Abstract][Full Text] [Related]
10. Perflubron emulsion improves hepatic microvascular integrity and mitochondrial redox state after hemorrhagic shock.
Paxian M; Keller SA; Huynh TT; Clemens MG
Shock; 2003 Nov; 20(5):449-57. PubMed ID: 14560110
[TBL] [Abstract][Full Text] [Related]
11. The effect of flow acceleration on the cyclic variation of blood echogenicity under pulsatile flow.
Huang CC; Liao CC; Lee PY; Shih CC
Ultrasound Med Biol; 2013 Apr; 39(4):670-80. PubMed ID: 23384462
[TBL] [Abstract][Full Text] [Related]
12. Comparison of different perfluorocarbons as ultrasound contrast agents.
Satterfield R; Tarter VM; Schumacher DJ; Tran P; Mattrey RF
Invest Radiol; 1993 Apr; 28(4):325-31. PubMed ID: 8478173
[TBL] [Abstract][Full Text] [Related]
13. MR imaging of Crohn disease: use of perflubron as a gastrointestinal contrast agent.
Anderson CM; Brown JJ; Balfe DM; Heiken JP; Borrello JA; Clouse RE; Pilgram TK
J Magn Reson Imaging; 1994; 4(3):491-6. PubMed ID: 8061454
[TBL] [Abstract][Full Text] [Related]
14. Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers.
Noveck RJ; Shannon EJ; Leese PT; Shorr JS; Flaim KE; Keipert PE; Woods CM
Anesth Analg; 2000 Oct; 91(4):812-22. PubMed ID: 11004031
[TBL] [Abstract][Full Text] [Related]
15. Ultrasonic backscatter from flowing whole blood. II: Dependence on frequency and fibrinogen concentration.
Yuan YW; Shung KK
J Acoust Soc Am; 1988 Oct; 84(4):1195-200. PubMed ID: 3058769
[TBL] [Abstract][Full Text] [Related]
16. The use of Imagent BP in diagnostic imaging research and 19F magnetic resonance for PO2 measurements.
Mattrey RF; Schumacher DJ; Tran HT; Guo Q; Buxton RB
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):917-20. PubMed ID: 1391533
[TBL] [Abstract][Full Text] [Related]
17. Echogenicity of sonographic contrast media at variable shear rates and concentrations.
Kallio T; Alanen A; Bondestam S
Acad Radiol; 1996 Aug; 3 Suppl 2():S312-4. PubMed ID: 8796589
[No Abstract] [Full Text] [Related]
18. A second-generation blood substitute (perflubron emulsion) increases the blood solubility of modern volatile anesthetics in vitro.
Cuignet OY; Baele PM; Van Obbergh LJ
Anesth Analg; 2002 Aug; 95(2):368-72, table of contents. PubMed ID: 12145053
[TBL] [Abstract][Full Text] [Related]
19. Ultrasonic characterization of blood during coagulation.
Shung KK; Fei DY; Yuan YW; Reeves WC
J Clin Ultrasound; 1984; 12(3):147-53. PubMed ID: 6423688
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound backscatter at 30 MHz from human blood: influence of rouleau size affected by blood modification and shear rate.
van der Heiden MS; de Kroon MG; Bom N; Borst C
Ultrasound Med Biol; 1995; 21(6):817-26. PubMed ID: 8571469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
